Related Experiment Videos
Nicotinamide and diabetes prevention
1University Hospital, London, Ontario, Canada.
Nutrition Reviews
|May 1, 1995
Summary
Immunologic testing can identify individuals at high risk for insulin-dependent diabetes mellitus (IDDM). A New Zealand study found nicotinamide treatment reduced new IDDM cases by 50% over five years, offering a potential prevention strategy.
Area of Science:
- Endocrinology
- Immunology
- Preventive Medicine
Background:
- Immunologic testing enables early identification of individuals predisposed to insulin-dependent diabetes mellitus (IDDM).
- Predicting IDDM onset opens avenues for disease prevention strategies.
- Previous research has explored various interventions for IDDM prevention.
Purpose of the Study:
- To evaluate the efficacy of nicotinamide as an intervention to prevent the development of IDDM in high-risk individuals.
- To assess the long-term impact of nicotinamide treatment on IDDM incidence.
Main Methods:
- An intervention study was conducted in New Zealand.
- High-risk individuals were identified using immunologic testing.
- Participants received nicotinamide treatment over a defined period.
Main Results:
- The study demonstrated a 50% reduction in the development of IDDM among participants receiving nicotinamide.
- The observed reduction was sustained over a 5-year follow-up period.
- Nicotinamide treatment proved effective in preventing new IDDM cases in the studied population.
Conclusions:
- Nicotinamide treatment represents a promising intervention for preventing insulin-dependent diabetes mellitus in at-risk populations.
- Early identification through immunologic testing combined with targeted treatment can significantly reduce IDDM incidence.
- Further research is warranted to confirm these findings and explore optimal treatment protocols.